Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazolones as modulators of TNF signaling

Indazolones as modulators of TNF signaling

US Patent 9879016 · Granted Jan 30, 2018

Estimated economic value: $149,887,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nicotinamide RIPK1 inhibitors2023
Modulation of rice MPG1 activity to increase biomass accumulation, grain yield, 2022
Sustained-release injectable formulation2021
Liquid precursor compositions and uses thereof for a ph-dependant sustained rele2020
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of u2020
Inhibitors of tyrosine kinase 2 mediated signaling2019
Inhibitors of tyrosine kinase 2 mediated signaling2019
Sustained release delivery systems for the prevention and treatment of head and 2019
Heterocyclic kinase inhibitors2019
Heterocyclic kinase inhibitors2019
Heterocyclic kinase inhibitors2019
Indazolones as modulators of TNF signaling2019